MedTrace Logo

Use of Maytenus Ilicifolia in the Treatment of Dyspepsia

NCT01408849 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2016-07-26

No results posted yet for this study

Summary

This study aims to evaluate the therapeutic effect of the infusion of Maytenus ilicifolia Mart. ex Reiss leaves, used for 8 weeks, on patients with dyspepsia. Primary endpoint is SODA score, secondary endpoint is endoscopic classification (Sydney).

Conditions

  • Dyspepsia

Interventions

DRUG

Maytenus ilicifolia leaves infusion

2 g of powdered leaves in 150 mL of boiling water, 3 times a day, for 8 weeks

DRUG

Omeprazole

Standard therapy

Sponsors & Collaborators

  • University of Sao Paulo

    collaborator OTHER

  • Casa Espirita Terra de Ismael

    lead OTHER

Principal Investigators

  • Ana MS Pereira, PhD · University of Ribeirao Preto

  • Jose S Santos, MD, PhD · HCFMRP-USP

  • Fabio Carmona, MD, PhD · HCFMRP-USP

  • Suzeidi B Castanheira, MD, PhD · HCFMRP-USP

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01408849 on ClinicalTrials.gov